{
    "id": 18152,
    "fullName": "BTK C481X",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BTK C481X indicates any BTK missense mutation that results in the cysteine (C) at amino acid 481 being replaced by a different amino acid.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 695,
        "geneSymbol": "BTK",
        "terms": [
            "BTK",
            "AGMX1",
            "AT",
            "ATK",
            "BPK",
            "IGHD3",
            "IMD1",
            "PSCTK1",
            "XLA"
        ]
    },
    "variant": "C481X",
    "createDate": "02/16/2016",
    "updateDate": "11/15/2019",
    "referenceTranscriptCoordinates": {
        "id": 143936,
        "transcript": "NM_000061",
        "gDna": "chrX:g.101356175_101356177",
        "cDna": "c.1441_1443",
        "protein": "p.C481",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12247,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, BTK C481X and/or PLCG2 mutations were identified in 80% (8/10) of patients with progressive disease and in 20% (1/5) of patients with prolymphocytic transformation of chronic lymphocytic leukemia while on Imbruvica (ibrutinib) treatment (PMID: 28049639, NCT01500733).",
            "molecularProfile": {
                "id": 18482,
                "profileName": "BTK C481X"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 1040,
                "name": "chronic lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10206,
                    "pubMedId": 28049639,
                    "title": "Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28049639"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18482,
            "profileName": "BTK C481X",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 143936,
            "transcript": "NM_000061",
            "gDna": "chrX:g.101356175_101356177",
            "cDna": "c.1441_1443",
            "protein": "p.C481",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}